Vistagen Therapeutics Inc (VTGN)
4.67
+0.02
(+0.43%)
USD |
NASDAQ |
Apr 17, 16:00
4.70
+0.03
(+0.64%)
Pre-Market: 08:47
Vistagen Therapeutics Total Assets (Quarterly): 131.07M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 131.07M |
| September 30, 2023 | 42.20M |
| June 30, 2023 | 15.03M |
| March 31, 2023 | 21.09M |
| December 31, 2022 | 29.71M |
| September 30, 2022 | 40.70M |
| June 30, 2022 | 58.73M |
| March 31, 2022 | 74.64M |
| December 31, 2021 | 90.54M |
| September 30, 2021 | 100.50M |
| June 30, 2021 | 103.91M |
| March 31, 2021 | 108.28M |
| December 31, 2020 | 109.27M |
| September 30, 2020 | 20.27M |
| June 30, 2020 | 6.167M |
| March 31, 2020 | 5.772M |
| December 31, 2019 | 5.331M |
| September 30, 2019 | 8.736M |
| June 30, 2019 | 12.95M |
| March 31, 2019 | 14.01M |
| December 31, 2018 | 7.522M |
| September 30, 2018 | 8.889M |
| June 30, 2018 | 8.255M |
| March 31, 2018 | 11.28M |
| December 31, 2017 | 14.24M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.618M |
| June 30, 2017 | 2.437M |
| March 31, 2017 | 3.712M |
| December 31, 2016 | 5.876M |
| September 30, 2016 | 7.023M |
| June 30, 2016 | 8.758M |
| March 31, 2016 | 0.9898M |
| December 31, 2015 | 2.012M |
| September 30, 2015 | 1.932M |
| June 30, 2015 | 1.744M |
| March 31, 2015 | 0.2697M |
| December 31, 2014 | 0.2594M |
| September 30, 2014 | 0.3869M |
| June 30, 2014 | 0.7647M |
| March 31, 2014 | 0.2637M |
| December 31, 2013 | 0.3289M |
| September 30, 2013 | 0.406M |
| June 30, 2013 | 0.4318M |
| March 31, 2013 | 0.8815M |
| December 31, 2012 | 0.326M |
| September 30, 2012 | 0.4246M |
| June 30, 2012 | 0.645M |
| March 31, 2012 | 0.3416M |
| December 31, 2011 | 0.3997M |
| September 30, 2011 | 0.5373M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.331M
Minimum
Dec 2019
131.07M
Maximum
Dec 2023
51.84M
Average
40.70M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Ardelyx Inc | 297.58M |
| Axsome Therapeutics Inc | 588.24M |
| Vir Biotechnology Inc | 1.919B |
| Immuneering Corp | 102.58M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.783M |
| Shareholders Equity (Quarterly) | 123.28M |
| Current Ratio | 30.76 |
| Net Debt Paydown Yield | 0.11% |